Innoviva Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innoviva Inc with three other
companies in this sector in UNITED STATES :
Corcept Therapeutics Incorporated
sales of $353.87 million
of which 100%
was tion of Pharmaceutical products),
Organogenesis Holdings Inc
of which 100%
was regenerative medicine), and
Amphastar Pharmaceuticals Inc
of which 95%
During the second
quarter of 2021, sales at Innoviva Inc totalled
an increase of 27.7%
from the $78.95 million in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled $186.32 million, which is
than through the first two quarters of 2020.
During the previous 6 quarters, sales at Innoviva Inc have increased compared with the same quarter in the previous year.
There appears to be at least some degree of seasonality in the sales at Innoviva Inc: during 8 of the previous 9
years, sales were highest during the fourth quarter.
The exception to this was during 2012, when the
first quarter was the best quarter, accounting for
94% of sales (during that same year, the
fourth quarter accounted for 4% of sales).
During the year ended December of 2020, sales at
Innoviva Inc were $336.79 million.
increase of 29.0%
versus 2019, when the company's sales were $261.02 million.
This was the fifth consecutive year of sales increases at Innoviva Inc
(and since 2015, sales have increased a total of 524%).